Article Details
Retrieved on: 2025-01-08 18:32:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
GSK (GSK) is in advanced discussions to purchase privately-owned U.S. biotech IDRx, which is working on a treatment for rare gastrointestinal tu.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here